Microscopic polyangiitis

2 trials 1 recruiting MedDRA PT
2 Registered trials
1 Recruiting
2 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

2 trials
  • Novartis Pharma AG Commercial
    IPTACOPAN
    2023-510525-15-00 9 countries 2024 n=44
    Ended
  • Charite Universitaetsmedizin Berlin KöR Academic
    IMLIFIDASE
    2024-516727-13-00 1 country 2023 n=10
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Novartis Pharma AG Commercial 1 Phase II 0
Charite Universitaetsmedizin Berlin KöR Academic 1 Phase II 1
New trials by year
2023
1
2024
1
← All indication landscapes